Skip to content

The role of exercise in treatment of women with Polycystic Ovary Syndrome (PCOS): mechanisms of action

A prospective cohort study examining the effect of 12 weeks of intensive endurance exercise on insulin sensitivity and muscle insulin signalling in overweight women with or without polycystic ovary syndrome (PCOS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84763265
Enrollment
30
Registered
2009-01-23
Start date
2005-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome Nutritional, Metabolic, Endocrine Ovarian dysfunction

Interventions

Both PCOS and non-PCOS women underwent the same study protocol. From baseline, participants in the two groups undertook a 12 week programme of supervised intensified endurance exercise (1 hr/day
3 x per week). Two different exercise sessions alternated, performing 1 hour of moderate intensity treadmill walking to elicit work rates of 70% of maximal oxygen consumption (VO2max) or 75 - 85% of m

Sponsors

Southern Health (Australia)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Overweight women (body mass index [BMI] greater than 27 kg/m^2) 2. Aged 18 - 40 years with PCOS and without 3. Diagnosed from a history of perimenarchal onset of irregular cycles (less than 21 days or greater than 35 days) 4. Clinical manifestations of hyperandrogenism (hirsutism, acne) or biochemical hyperandrogenism with elevation of at least one circulating ovarian androgen (1990 National Institute of Health [NIH] criteria)

Exclusion criteria

Exclusion criteria: 1. BMI less than 27 kg/m^2 2. Other concurrent medical conditions 3. Ongoing use of the oral contraceptive pill (OCP) 4. Pregnancy or desire for pregnancy 5. Secondary causes of amenorrhoea and hyperandrogenism

Design outcomes

Primary

MeasureTime frame
Effects on insulin resistance, measured at baseline and after 12 weeks of exercise.

Secondary

MeasureTime frame
1. Clinical symptom improvement 2. Insulin signalling 3. Mitochondrial function Measured at baseline and after 12 weeks of exercise.

Countries

Australia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026